In addition, we also found that the combination of FLX and necroptosis inhibitors (Nec-1, GSK872 or NSA) could produce synergistic pharmacological effects in reducing Cort-induced cell death, which could provide a new strategy for the clinical treatment of depression. This evidence concerns the gene PCSK1 and depressive symptom measurement.